Colgate-Palmolive (CL) Stake Lessened by Orrstown Financial Services Inc.

Orrstown Financial Services Inc. trimmed its stake in shares of Colgate-Palmolive (NYSE:CL) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,760 shares of the company’s stock after selling 470 shares during the period. Orrstown Financial Services Inc.’s holdings in Colgate-Palmolive were worth $120,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares in the last quarter. Vanguard Group Inc raised its position in shares of Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares in the last quarter. BlackRock Inc. raised its position in shares of Colgate-Palmolive by 13.5% in the 4th quarter. BlackRock Inc. now owns 60,648,605 shares of the company’s stock valued at $3,609,804,000 after buying an additional 7,236,342 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Colgate-Palmolive by 3.2% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 32,521,377 shares of the company’s stock valued at $1,935,674,000 after buying an additional 1,000,161 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Colgate-Palmolive by 1.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 20,359,199 shares of the company’s stock valued at $1,363,050,000 after buying an additional 223,814 shares in the last quarter. Institutional investors and hedge funds own 76.22% of the company’s stock.

Colgate-Palmolive stock opened at $71.30 on Friday. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.76 and a current ratio of 1.14. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $71.50. The firm has a market cap of $61.30 billion, a P/E ratio of 24.01, a P/E/G ratio of 4.53 and a beta of 0.79.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, April 26th. The company reported $0.67 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.01. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The firm had revenue of $3.88 billion for the quarter, compared to the consensus estimate of $3.86 billion. During the same quarter in the prior year, the company posted $0.74 earnings per share. The business’s revenue was down 2.9% on a year-over-year basis. On average, equities research analysts expect that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.43 dividend. The ex-dividend date is Wednesday, April 17th. This represents a $1.72 annualized dividend and a dividend yield of 2.41%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.

A number of equities analysts recently issued reports on the stock. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Tuesday. UBS Group upped their price objective on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, March 29th. Citigroup set a $68.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Tuesday, March 19th. Credit Suisse Group began coverage on shares of Colgate-Palmolive in a report on Wednesday, March 6th. They set an “underperform” rating on the stock. Finally, BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $56.00 to $67.00 in a report on Monday, February 11th. Three equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $65.73.

In related news, CEO Ian M. Cook sold 22,634 shares of the stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the completion of the transaction, the chief executive officer now owns 1,162,793 shares in the company, valued at $77,104,803.83. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director John T. Cahill sold 5,780 shares of the stock in a transaction dated Thursday, January 31st. The shares were sold at an average price of $64.46, for a total transaction of $372,578.80. Following the transaction, the director now owns 27,820 shares of the company’s stock, valued at approximately $1,793,277.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 103,200 shares of company stock valued at $6,900,449. 1.14% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “Colgate-Palmolive (CL) Stake Lessened by Orrstown Financial Services Inc.” was reported by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.baseballdailydigest.com/news/2019/04/27/orrstown-financial-services-inc-sells-470-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Recommended Story: Gap Up Stocks

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.